Our partner’s, PBL, specialty lies in interferon. They’ve ensured that the IFN-Alpha ELISAs provide users with low-level subtype quantification, global detection, and reproducible inter- (<10%) and intra-assay (<8%) CVs:
- Robust Matrix Tolerance: Verikine-HS Human IFN-Alpha All Subtype ELISA, High Sensitivity (Cat. # 41115-1)
- Tissue Culture Media Compatible: Verikine-HS Human IFN-Alpha All Subtype TCM ELISA, High Sensitivity (Cat. # 41135-1)
Recent Publications
- Peluso, Michael, et al. (2020). “Liver function test abnormalities in a longitudinal cohort of Thai individuals treated since acute HIV infection”. PLOS Pathogens.
- Dagenais-Lussier, Xavier, et al. (2019). “USP18 is a Significant Driver of Memory CD4 T-cell Reduced Viability Caused by Type I IFN Signaling During Primary HIV-1 Infection”. PLOS Pathogens.
- Colavita, Francesca, et al. (2018). “Overproduction of IL-6 and Type-I IFN in a Lethal Case of Chikungunya Virus Infection in an Elderly Man During the 2017 Italian Outbreak”. Open Forum Infectious Diseases.